FDA-Warned Sexual Enhancement Products: Complete List

The Food and Drug Administration (FDA) regularly publishes notifications about sexual enhancement and energy products. Testing has revealed that some of these products have been found to contain undeclared drug ingredients. These hidden compounds include sildenafil, tadalafil, and other phosphodiesterase type 5 (PDE-5) inhibitors or their analogs. Because these active pharmaceutical ingredients are undisclosed, consumers face serious, unknown health risks and potential drug interactions.

Importantly, a product’s absence from the FDA’s list does not mean it is safe. The agency’s notification database captures only a fraction of contaminated items on the market, making consumer caution and professional medical consultation essential. This guide covers the FDA-warned sexual enhancement products list, what these warnings mean, the dangers of hidden ingredients, what steps to take if you have used a listed product, and the bottom line.

FDA-Warned Sexual Enhancement Products List

The FDA’s sexual-enhancement and energy notification page is a public-health warning database, not a complete list of every potentially unsafe product. It identifies products found via FDA testing to contain undeclared drug ingredients, including products marketed as supplements, energy pills, honey, chocolates, and “all-natural” treatments. This matters because marketing claims do not reveal a product’s actual contents. Some products may contain pharmaceutical ingredients without clearly disclosing them.

The FDA considers contaminated products of this kind a form of medication health fraud. Positive reviews, online popularity, or natural claims do not establish safety or accurate labeling. Because consumers may not know what drug is present or how much they are taking, hidden ingredients can create unexpected interactions and potentially serious health risks. The following table details some of the products that the FDA has publicly flagged due to the presence of hidden, undeclared, or dangerous drug ingredients [1]:

Product	Hidden Ingredient(s)	FDA Warning Date	Product Uses/Type	FDA Notice
Kangaroo Intense Venus 3000	sildenafil	07/23/2026	sexual enhancement pill	Official public notification
MAGNUM Brand Products	sildenafil, tadalafil	07/01/2026	sexual enhancement (in various dosage forms including capsules and honey)	Official public notification
Branch Manager for Men	yohimbine (dangerously high levels)	06/10/2026	male sexual enhancement	Official public notification
Business Pill	yohimbine (dangerously high levels)	06/10/2026	male sexual enhancement	Official public notification
Pink Pussycat Brand Products	Pink Pussycat Liquid Shot contains sildenafil, and Pink Pussycat Honey contains sildenafil and tadalafil	06/05/2026	female sexual enhancement (in various dosage forms including capsules, liquids, honey and chocolate)	Official public notification
Juicy AF!	sildenafil	06/04/2026	female sexual enhancement	Official public notification
Big Dick Energy!	tadalafil, sildenafil	05/29/2026	male sexual enhancement	Official public notification
X10 Natural Enhancement Supplement	sildenafil, tadalafil	05/29/2026	male sexual enhancement	Official public notification
Erectus Plus	sildenafil, tadalafil, testosterone propionate	05/29/2026	male sexual enhancement	Official public notification
Sensual Miracle Honey	sildenafil, tadalafil	05/29/2026	sexual enhancement honey	Official public notification
biQ-FEL	sildenafil, tadalafil	05/27/2026	sexual enhancement	Official public notification
HARD AF!	sildenafil, tadalafil (2026); sildenafil and acetaminophen (2021)	05/07/2026	male sexual enhancement	Official public notification
WAP Sensual Enhancement	sildenafil, tadalafil, flibanserin	04/07/2026	female sexual enhancement capsules	Official public notification
Red Bull Extreme / Blue Bull Extreme	sildenafil	03/30/2026	sexual enhancement honey/supplement	Official public notification
Boner Bears Honey	sildenafil, tadalafil	03/30/2026	sexual enhancement honey	Official public notification
LOVION Chocolate with Ginseng for Men	sildenafil, tadalafil	02/13/2026	sexual enhancement chocolate	Official public notification
Fantasy Aphrodisiac Chocolate	sildenafil	02/13/2026	sexual enhancement chocolate	Official public notification
DTF Sexual Chocolate	sildenafil, tadalafil	02/13/2026	sexual enhancement chocolate	Official public notification
Boner Bears (Chocolate/Syrup)	sildenafil	02/17/2026	sexual enhancement chocolate/syrup	Official public notification
Rhino Choco VIP Chocolate for Men	tadalafil	02/11/2026	sexual enhancement chocolate	Official public notification

Tip: Several other FDA notices exist, including Anaconda Premium 500K and Premium OrgaZEN 10000. Don’t judge a sexual-enhancement product by its label, marketing claims, or popularity alone. The concern is ongoing, not limited to older cases. Finally, the FDA’s database represents only a small fraction of contaminated products, so absence from the list is not proof of safety. If a product isn’t on the list, that doesn’t mean it’s safe. Talk to a healthcare professional before buying or trying a new product for your health.

What Does an FDA Warning Mean?

From both a medical and editorial perspective, it is important to distinguish an FDA warning or public notification from FDA approval and an automatic product “ban.” These terms describe different regulatory actions. Confusing them can create dangerous assumptions about a product’s safety, effectiveness, or legal status.

FDA Warning/Public Notification: What It Means

An FDA public notification alerts consumers, healthcare professionals, retailers, and other stakeholders to a specific safety or regulatory concern. In the sexual-enhancement category, the FDA may issue a notification after laboratory testing or other regulatory action identifies undeclared pharmaceutical ingredients, adulteration, misbranding, or another health concern. In such cases, the FDA advises consumers not to purchase or use the affected product. These notifications are part of the agency’s broader medication-health-fraud and consumer-protection activities.

FDA Warning ≠ FDA Approval

An FDA warning does not mean that the product was previously FDA-approved. This is particularly important for dietary supplements. Unlike prescription drugs, dietary supplements generally do not undergo FDA premarket approval for safety or effectiveness before being marketed. FDA approval applies to specific drugs, formulations, labeling, intended uses, and regulatory applications. Therefore, finding an approved pharmaceutical ingredient such as sildenafil or tadalafil in an otherwise unapproved product does not make the product FDA-approved. An approved ingredient cannot transfer its regulatory approval to a different, unapproved product.

FDA Warning ≠ Automatic “Ban”

An FDA notification should also not automatically be described as a “ban.” Depending on the circumstances, the FDA can use different regulatory and enforcement mechanisms, including voluntary recalls, warning letters, import actions, seizures, injunctions, and other authorized measures to address adulterated or misbranded products and prevent their distribution. While the FDA may issue a warning letter allowing a company a specific timeframe (typically 15 working days) to respond formally and outline a corrective action plan, the agency expects the immediate cessation of distribution and recall of the adulterated product to protect public health.

A Product Not on the FDA List Is Not Automatically Safe

This is perhaps the most important distinction. Absence from the FDA’s notification database does not mean FDA approval, testing, or a finding of safety. The FDA states that its sexual-enhancement and energy-product notification list represents only a small fraction of contaminated products on the market. The agency cannot test every product being sold online, through retailers, or through changing distribution channels. Therefore, a product not on the list should not be described as FDA-approved, FDA-tested, or proven safe simply because the FDA has not issued a notification.

What Hidden Ingredients Has the FDA Found?

The ingredients identified in these notifications are not harmless label omissions. They include prescription-level substances that normally require medical oversight. Before prescribing such medicines, a doctor considers factors such as cardiovascular health, blood pressure, existing conditions, allergies, and other medications. Knowing exactly what drug is being taken—and at what dose—is essential because certain combinations can cause serious interactions. Some of the hidden ingredients include:

Sildenafil

Sildenafil is a PDE-5 inhibitor and the active ingredient in Viagra, an FDA-approved prescription medicine for the treatment of erectile dysfunction (ED) [1]. It is also used in other formulations for pulmonary arterial hypertension, although the dosage, formulation, and treatment context differ from those used for ED.

For ED, sildenafil works through the nitric oxide–cyclic guanosine monophosphate (cGMP) pathway. Sexual stimulation triggers nitric oxide (NO) release in penile tissue, increasing cGMP levels and promoting smooth muscle relaxation in penile blood vessels. Sildenafil inhibits the PDE-5 enzyme responsible for breaking down cGMP, thereby helping maintain the signaling involved in penile blood-flow changes during sexual stimulation.

Importantly, sildenafil does not independently create sexual desire or produce an erection simply because the drug is present. Its approved use for ED is associated with improved erectile function in the presence of sexual stimulation. Sildenafil’s terminal elimination half-life is approximately 4 hours. For an approved prescription medicine, the dose and formulation are known, and the prescribing process provides an opportunity to assess whether sildenafil is appropriate for the individual.

Tadalafil

Tadalafil is another PDE-5 inhibitor and the active ingredient in Cialis, an FDA-approved prescription medicine used to treat ED. It’s also approved for other medical uses, including benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension, depending on the formulation and prescribed dose. Like sildenafil, tadalafil works primarily through the PDE-5/cGMP pathway [3].

One of the most important pharmacological differences between tadalafil and sildenafil is the time tadalafil remains in the body. Tadalafil has an elimination half-life of approximately 17.5 hours, considerably longer than sildenafil’s roughly 4-hour half-life. Its longer pharmacokinetic profile contributes to tadalafil’s well-known extended duration of erectile-function effects. After a dose, its ability to support erectile function can persist for up to 36 hours. This does not mean that an erection lasts for 36 hours; rather, the medication can continue to improve erectile responsiveness during that period when sexual stimulation occurs.

Other Undeclared Drug Ingredients

The FDA’s findings show that hidden ingredients in sexual-enhancement products are not limited to sildenafil or tadalafil. Different products have contained pharmacologically active substances with very different medical uses, including drugs that affect neurotransmitter systems, cardiovascular signaling, hormones, pain, or appetite. Examples include:

• Flibanserin: The active ingredient in Addyi, an FDA-approved prescription medicine used for the treatment of premenopausal women with hypoactive sexual desire disorder. The med improves sexual desire, increases the number of satisfying sexual events, and reduces the distress linked with low sexual desire [4]. Unlike sildenafil and tadalafil, flibanserin is not a PDE-5 inhibitor; it acts on neurotransmitter systems in the brain;
• Yohimbine: It’s a pharmacologically active compound derived from the bark of the yohimbe tree. Rather than functioning like a PDE-5 inhibitor, yohimbine affects adrenergic signaling and has historically been investigated and marketed for sexual-function-related purposes;
• Testosterone propionate: This product is an androgenic hormone used in testosterone therapy. Testosterone products are used medically when testosterone replacement is appropriate, making this finding particularly different from the typical ED ingredients identified in FDA notifications;
• Sibutramine: It’s a centrally acting appetite suppressant formerly used to manage weight but has been discontinued in many countries. Desmethyl sibutramine is a pharmacologically active metabolite of sibutramine. These findings demonstrate that hidden ingredients can extend well beyond medicines normally associated with ED;
• Acetaminophen: It’s an analgesic and fever-reducing medicine commonly used to relieve mild-to-moderate pain and reduce fever.

Taken together, these findings show there is no single pattern for undeclared ingredients. FDA testing has identified substances with different therapeutic purposes and mechanisms, sometimes several in the same product.

Why Are Hidden ED Drug Ingredients Dangerous?

Hidden ED drug ingredients are more than a labeling problem because consumers may unknowingly take pharmacologically active medicines without reliable information about the dose, ingredients, or potential interactions. Some of the dangers include:

• unknown product and dosage: When a pharmaceutical ingredient is not disclosed on the label, consumers cannot reliably determine how much they are taking, making it impossible to make informed decisions about exposure. The fundamental problem is that an inaccurately labeled product prevents consumers and healthcare providers from knowing what substances have actually been consumed, which can complicate medication decisions and the assessment of unexpected symptoms;
• drug interactions: Undeclared PDE-5 inhibitors can interact with various medicines, including those used for cardiovascular conditions, blood pressure management, or other health problems, potentially producing effects that the consumer did not anticipate;
• the risk for people taking nitrates: This is particularly important because sildenafil and tadalafil can interact with nitrate medicines such as nitroglycerin, causing blood pressure to fall dangerously low; the FDA specifically highlights this interaction as a serious safety concern. Combining an undisclosed PDE-5 inhibitor with nitrates or certain other meds that lower blood pressure can produce excessive hypotension, potentially resulting in serious symptoms such as dizziness, fainting, or other cardiovascular complications that require urgent medical assessment;
• deceptive “natural” marketing: Products may be promoted as “natural,” “herbal,” or “plant-based,” creating an impression of safety even when FDA laboratory testing has identified pharmaceutical ingredients never disclosed on the label, demonstrating why marketing language should never substitute for reliable ingredient information.

Furthermore, some products contain a mix of two or more undisclosed pharmaceutical ingredients, meaning consumers may unknowingly take multiple active substances at once. This creates greater uncertainty around dosage, interactions, and individual safety, particularly when ingredients such as sildenafil and tadalafil are combined.

Such combinations also interact with other drugs, contributing to dangerous side effects. Therefore, multiple hidden ingredients should not be viewed simply as a stronger supplement, but as an unpredictable exposure with potentially serious risks.

What to Do If You Have Used a Product on This List

If you discover you purchased or used a product identified in an FDA notification, do not assume the product is safe because it was marketed as natural, herbal, or a dietary supplement. Stop using the product and avoid consuming any remaining pills, honey, chocolate, or other forms of the product until you have reviewed the relevant safety information and obtained appropriate advice.

Do not rely on the product as a safe alternative to properly evaluated and appropriately prescribed medication. Check the specific FDA notification for the product on the FDA’s official website and review important details such as the product name, lot number, expiration date, recognized hidden ingredients, and the agency’s recommendations.

If you experience serious or unexpected symptoms, seek prompt medical attention, particularly if you develop chest pain, severe dizziness, fainting, an irregular heartbeat, or other concerning symptoms. Tell the doctor exactly what product you used so they can consider possible drug exposure or interactions when assessing your situation.

Finally, consider speaking with a qualified healthcare professional about the underlying health concern the product was intended for use. A clinician can review your medical history, current meds, and individual circumstances when discussing appropriate treatment options.

The Bottom Line on FDA-Warned Sexual Enhancement Products

Ultimately, sexual health is part of overall health, and FDA warnings expose a serious problem in the internet drug market: various sexual enhancement products can contain undeclared drugs such as sildenafil and tadalafil. The risk is not merely misleading advertising; unknown doses and hidden ingredients can cause dangerous interactions leading to severe side effects. An FDA warning is not the same as an automatic ban, and a product absent from the FDA list is not necessarily safe.

Never choose a sexual enhancement product solely because of online reviews, attractive claims, or a “natural” label. If medication is medically appropriate, choose legitimate, properly labeled medicines from known pharmaceutical manufacturers and reputable, regulated sources, with appropriate healthcare guidance. When a product’s origin or ingredients cannot be verified, avoid it rather than gamble with your health.

References:

1. Sexual Enhancement and Energy Product Notifications. Retrieved: August 18, 2026. Fda.gov.
2. Sildenafil. Retrieved: August 18, 2026. Wikipedia.org.
3. Tadalafil. Retrieved: August 18, 2026. Wikipedia.org.
4. Flibanserin. Retrieved: August 18, 2026. Wikipedia.org.